VBI Vaccines Inc
General ticker "VBIV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $874.4K
VBI Vaccines Inc does not follow the US Stock Market performance with the rate: -13.4%.
Estimated limits based on current volatility of 15.7%: low 0.02$, high 0.03$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.96$, 4.32$]
- 2024-12-30 to 2025-12-30 estimated range: [2.99$, 10.00$]
Financial Metrics affecting the VBIV estimates:
- Negative: Non-GAAP EPS of -7.38 <= 0.08
- Negative: Operating Income to Revenue ratio of -0.86 <= 0.01
- Negative: negative Net Income
- Negative: Operating Cash Flow per share of -3.91 <= 0.20
- Negative: Industry Operating Cash Flow per share (median) of -1.55 <= 0.28
Short-term VBIV quotes
Long-term VBIV plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.63MM | $1.08MM | $8.68MM |
| Operating Expenses | $68.66MM | $82.90MM | $63.99MM |
| Operating Income | $-68.03MM | $-81.82MM | $-55.31MM |
| Non-Operating Income | $-1.72MM | $-31.48MM | $-37.52MM |
| Interest Expense | $4.73MM | $4.01MM | $8.06MM |
| R&D Expense | $19.56MM | $15.51MM | $9.34MM |
| Income(Loss) | $-69.75MM | $-113.30MM | $-92.84MM |
| Profit(Loss) | $-69.75MM | $-113.30MM | $-92.84MM |
| Stockholders Equity | $143.88MM | $64.16MM | $7.53MM |
| Assets | $210.28MM | $155.09MM | $86.95MM |
| Operating Cash Flow | $-39.91MM | $-73.69MM | $-60.88MM |
| Investing Cash Flow | $23.16MM | $-4.34MM | $-0.87MM |
| Financing Cash Flow | $44.29MM | $19.45MM | $22.70MM |
| Earnings Per Share* | $-8.55 | $-16.37 | $-5.96 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.